Tech Company Financing Transactions
NeuroFlow Funding Round
Concord Health Partners invested in a capital raise for NeuroFlow. The funding round was announced on 9/7/2023.
Transaction Overview
Company Name
Announced On
9/7/2023
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
Concord Health Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to continue to expand operations, and its business reach within the complex payor and government agency segments.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
1635 Market St.
Philadelphia, PA 19103
USA
Philadelphia, PA 19103
USA
Phone
Undisclosed
Website
Email Address
Overview
?NeuroFlow is a digital health company changing the way we see brain health. CEO and co-founder, Chris Molaro, believes that the brain is one of the greatest last frontiers of science and technology. Our minds are connected to our bodies - and in a way that we can measure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Molaro
Chief Operating Officer
Adam Pardes
VP - Customer Service
Jung-Hyun Kim
VP - Finance
Austin Conner
VP - Operations
Matthew Miclette
VP - Product Management
Julia Kastner
Browse more venture capital transactions:
Prev: 9/7/2023: Ello venture capital transaction
Next: 9/7/2023: Gradient Denervation Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs